Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Active not recruiting 4Completed 3Terminated 2Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 32OTHER 26NETWORK 2OTHER_GOV 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2

Interventions

Radiotherapy 41Cisplatin 36Fluorouracil 17Paclitaxel 15Docetaxel 14Cyclophosphamide 14Carboplatin 14Filgrastim 13Doxorubicin 13Gemcitabine 11Etoposide 11Capecitabine 10Surgical Procedures, Operative 9Methotrexate 9Leucovorin 9Chemotherapy, Adjuvant 9Vincristine 8Peripheral Blood Stem Cell Transplantation 8Oxaliplatin 8Dexamethasone 7Bevacizumab 7Topotecan 6Radiotherapy, Conformal 6Prednisone 6Fenretinide 6Cetuximab 6Neoadjuvant Therapy 5Mitomycin 5Irinotecan 5Ifosfamide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × NETWORK × Fulvestrant × Clear all
NCT02137837 2021-01-28

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

SWOG Cancer Research Network

Phase 3 Terminated
37 enrolled 16 charts
Breast

Breast Neoplasms

NCT00010153 2012-07-19

ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡